Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Briggs Morrison Insider Profile
11 Followers
Briggs Morrison, Director at Syndax Pharmaceuticals, holds 30.00K shares in Arvinas Holding Company (Ticker: ARVN), holds 34.84K shares in Syndax Pharmaceuticals (Ticker: SNDX), holds ― shares in NextCure (Ticker: NXTC).
Profitable Transactions
7 out of 12 Profitable Transactions
Average Return
+30.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Briggs Morrison holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Oct 11, 2019 - Oct 11, 2020
Return:+155.30%
The most profitable trade made by Briggs Morrison
Briggs Morrison's Trading History
Syndax Pharmaceuticals
Feb 09, 2024
Director
Uninformative Buy
―
$707.87K
Arvinas Holding Company
May 31, 2024
Director
Uninformative Buy
―
$732.80K
NextCure
―
Director
―
―
Repare Therapeutics
Jun 25, 2020
Director
Informative Buy
96.00K
$14.26K
Codiak BioSciences
Feb 17, 2021
―
Informative Buy
99.98K
$52.37
Werewolf Therapeutics
―
Director
―
―
Carisma Therapeutics
Mar 09, 2023
Director
Uninformative Buy
―
$14.49K
List of latest transactions for each holding click on a transaction to see Briggs Morrison's performance on stock
You May Also Like
Briggs Morrison insider profile FAQ
What is the percentage of profitable transactions made by Briggs Morrison?
The percentage of profitable transactions made by Briggs Morrison is 58%.
What is the average return per transaction made by Briggs Morrison?
The average return per transaction made by Briggs Morrison is 30.70%.
What stocks does Briggs Morrison hold?
Briggs Morrison holds: SNDX, ARVN, NXTC, RPTX, CDAKQ, HOWL, CARM stocks.
What was Briggs Morrison’s latest transaction?
Briggs Morrison latest transaction was an Uninformative Buy of ―.
What was Briggs Morrison's most profitable transaction?
Briggs Morrison’s most profitable transaction was an Informative Buy of SNDX stock on October 11, 2019. The return on the trade was 155.30%.
What is Briggs Morrison's role in Syndax Pharmaceuticals?
Briggs Morrison's role in Syndax Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.